Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
15.6%
% of CANC's 45 holdings also in PBE
25.0%
% of PBE's 28 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 6.1% | 5.4% | 5.4% |
|
AMGEN INC | 4.3% | 4.9% | 4.3% |
|
ILLUMINA INC | 3.3% | 5.7% | 3.3% |
|
GILEAD SCIENCES INC | 3.0% | 5.5% | 3.0% |
|
INCYTE CORP | 2.8% | 5.1% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PBE
 |
ASTRAZENECA PLC | 6.0% |
|
MERCK & CO. INC. | 4.3% |
 |
DAIICHI SANKYO CO LTD | 3.8% |
 |
ARGENX SE ADR | 3.7% |
|
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
REVOLUTION MEDICINES, INC. | 3.1% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 2.7% |
 |
NOVARTIS AG | 2.6% |
|
INTELLIA THERAPEUTICS, INC. | 2.5% |
|
BEIGENE LTD. SPONSORED ADR | 2.4% |
CANC Underweight Relative to PBE
|
BIOMARIN PHARMACEUTICAL INC | -5.4% |
|
VERTEX PHARMACEUTICALS INC | -4.9% |
|
NEUROCRINE BIOSCIENCES INC | -4.0% |
|
HALOZYME THERAPEUTICS INC | -3.6% |
|
VERACYTE INC | -3.6% |
|
TG THERAPEUTICS INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.3% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |
|
OPKO HEALTH INC | -3.0% |
|
CATALYST PHARMACEUTICAL PART | -3.0% |